NDC 0085-2224

NOXAFIL

Posaconazole

NOXAFIL is a Oral Powder, For Suspension in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Posaconazole.

• Product ID: 0085-2224_4074d802-2e64-450e-aa7f-217b011d8324
• NDC: 0085-2224
• Product Type: Human Prescription Drug
• Proprietary Name: NOXAFIL
• Generic Name: Posaconazole
• Dosage Form: Powder, For Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2021-06-08
• Marketing Category: NDA /
• Application Number: NDA214770
• Labeler Name: Merck Sharp & Dohme Corp.
• Substance Name: POSACONAZOLE
• Active Ingredient Strength: 300 mg/1
• Pharm Classes: Azole Antifungal [EPC],Azoles [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 0085-2224-02

8 PACKET in 1 CARTON (0085-2224-02) > 1 POWDER, FOR SUSPENSION in 1 PACKET (0085-2224-01)

• Marketing Start Date: 2021-06-08
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "NOXAFIL" or generic name "Posaconazole"

NDC	Brand Name	Generic Name
0085-1328	NOXAFIL	posaconazole
0085-2224	NOXAFIL	posaconazole
0085-4324	NOXAFIL	posaconazole
0085-4331	NOXAFIL	posaconazole
0254-2045	POSACONAZOLE	posaconazole
0406-7711	POSACONAZOLE	posaconazole
0527-2133	POSACONAZOLE	Posaconazole